Real-world Treatment Patterns and Outcomes in HR+/HER2+ Metastatic Breast Cancer Patients: A National Cancer Database Analysis

Treatment patterns and outcomes are unclear for metastatic breast cancer (MBC) patients diagnosed with hormone receptor-positive (HR+), human epidermal growth factor 2-positive (HER2+) disease. This study aimed to: (1) examine the utilization of first-line therapy among HR+/HER2+/MBC patients and (2...

Descripción completa

Detalles Bibliográficos
Autores principales: Statler, Abby B., Hobbs, Brian P., Wei, Wei, Gupta, Annie, Blake, Cassann N., Nahleh, Zeina A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889133/
https://www.ncbi.nlm.nih.gov/pubmed/31792304
http://dx.doi.org/10.1038/s41598-019-54402-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889133/
https://www.ncbi.nlm.nih.gov/pubmed/31792304
http://dx.doi.org/10.1038/s41598-019-54402-9

Ejemplares similares